trial · primary record
JANX007
Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 272 |
| Primary completion | 2028-12 |
| Primary endpoint | Incidence of Dose Limiting Toxicities (DLT) |
| Registry ID | NCT05519449 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.413Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05519449
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.